TECX Tectonic Therapeutic, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$22,54
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$14,6052 haftanın en düşüğü
$39,5352 haftanın en yükseği
Piyasa Değeri (MRQ)
$434M
P/E
-5.6
Hisse Başına Kâr
$-4.05
rozetleriniz
52 Haftlık Aralık
$15–$40
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$77
P/E
-5.6
ROE
-27.7%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
TECX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$22.54
Piyasa Değeri (MRQ)
$434M
P/E
-5.6
Hisse Başına Kâr
$-4.05
ROE
-27.7%
52 Haftlık Aralık
$15–$40
TECX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 21 Haziran 2024 | 1-for-12 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-4.052021-12-31 → 2025-12-31
Serbest Nakit Akışı$-60M2018-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | TECX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -5.65Y ort. ≈-6.5 | ≈-6.5 | · | · | |
| F/D (MRQ) | 1.95Y ort. ≈6.1 | ≈6.1 | 3.0 | Adil değer | |
| Fiyat / Serbest Nakit Akışı (TTM) | -6.05Y ort. ≈-10.5 | ≈-10.5 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -6.05Y ort. ≈-10.6 | ≈-10.6 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 1.75Y ort. ≈5.9 | ≈5.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | TECX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -35.8%5Y ort. ≈-40.6% | ≈-40.6% | -42.2% | En üst düzey | |
| ROE | -27.7%5Y ort. ≈-18.5% | ≈-18.5% | -78.7% | En üst düzey | |
| ROIC | -34.0% | · | -67.4% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | TECX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 22.35Y ort. ≈14.6 | ≈14.6 | 5.1 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 26.35Y ort. ≈14.1 | ≈14.1 | 2.9 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
4.4%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 19, 2026 | $-1.18 | $-1.38 | 14.6% |
| 31 Mart 2026 | $-1.34 | $-1.21 | -11.1% | |
| 31 Aralık 2025 | $-1.03 | $-1.13 | 8.5% | |
| 30 Eylül 2025 | $-1.02 | $-1.07 | 4.5% | |
| 30 Haziran 2025 | $-1.07 | $-1.00 | -6.9% | |
| 31 Mart 2025 | $-0.93 | $-1.11 | 16.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $63M | $41M | $37M | $72M | $83M | $87M | $55M | $35M | $15M | |
| SG&A Expense | $21M | $17M | $8M | $33M | $36M | $33M | $21M | $11M | $3M | |
| Operating Expenses | $84M | $58M | $45M | $105M | $119M | $120M | $76M | $46M | $18M | |
| Operating Income | $-84M | $-58M | $-45M | $-105M | $-119M | $-120M | $-76M | $-46M | $-18M | |
| Interest Income | $11M | $4M | $581.0K | · | · | $719.0K | $3M | $2M | $57.0K | |
| Other Non-op | $-119.0K | $-511.0K | $396.0K | $-456.0K | $-285.0K | $516.0K | $3M | $-118.0K | $-262.0K | |
| Pretax Income | $-73M | $-58M | · | · | · | · | · | · | · | |
| Income Tax | $1M | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-74M | $-58M | $-43M | $-106M | $-119M | $-120M | $-73M | $-46M | $-19M | |
| EPS (Basic) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · | |
| EPS (Diluted) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · | |
| Shares (Basic) | 18,322,533 | 8,490,171 | 1,268,512 | 43,739,000 | 42,854 | · | · | · | · | |
| Shares (Diluted) | 18,322,533 | 8,490,171 | 1,268,512 | 43,739,000 | 42,854 | · | · | · | · | |
| EBITDA | $-83M | $-56M | $11M | $-104M | $-117M | $-119M | $-75M | $-46M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $254M | $141M | $29M | $93M | $190M | $260M | $187M | $126M | $6M | |
| Prepaid Expense | $3M | $6M | $2M | $7M | $10M | $8M | $9M | $4M | $345.0K | |
| Other Current Assets | · | · | $570.0K | $1M | $2M | $271.0K | $344.0K | $795.0K | $60.0K | |
| Current Assets | $257M | $147M | $31M | $100M | $199M | $267M | $196M | $130M | $6M | |
| PP&E (Net) | $1M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $349.0K | |
| PP&E (Gross) | $5M | $5M | $5M | $7M | $8M | $5M | $5M | $3M | $394.0K | |
| Accum. Depreciation | $3M | $3M | $2M | $4M | $4M | $2M | $1M | $384.0K | $45.0K | |
| Other Non-current Assets | $640.0K | $156.0K | $31.0K | $40.0K | $74.0K | $436.0K | $625.0K | $825.0K | $365.0K | |
| Total Assets | $261M | $153M | $39M | $104M | $204M | $271M | $201M | $133M | $7M | |
| Accounts Payable | $1M | $976.0K | $409.0K | $384.0K | $3M | $3M | $4M | $3M | $527.0K | |
| Accrued Liabilities | $7M | $8M | $8M | $12M | $16M | $14M | $10M | $8M | $2M | |
| Current Liabilities | $10M | $12M | $41M | $13M | $19M | $17M | $14M | $11M | $3M | |
| Capital Leases | $0 | $132.0K | $2M | $188.0K | $0 | · | · | · | · | |
| Deferred Tax | · | · | $0 | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | $500.0K | |
| Total Liabilities | $10M | $12M | $43M | $29M | $34M | $17M | $15M | $11M | $4M | |
| Long-term Debt | · | · | · | $15M | $15M | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $0 | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | · | |
| Paid-in Capital | $474M | $289M | $6M | · | · | · | · | · | · | |
| Retained Earnings | $-223M | $-149M | $-91M | $-489M | $-384M | $-264M | $-145M | $-72M | $-23M | |
| AOCI | $-96.0K | $9.0K | $-11.0K | · | · | · | · | · | · | |
| Stockholders' Equity | $251M | $141M | $-85M | $-46M | $169M | $254M | $186M | $122M | $-23M | |
| Liabilities + Equity | $261M | $153M | $39M | $104M | $204M | $271M | $201M | $133M | $7M | |
| Shares Outstanding | 18,738,249 | 14,856,309 | 1,407,753 | 43,916,000 | 43,652,000 | 43,652,000 | 31,643,000 | 23,806,628 | 2,305,173 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $2M | $1M | $1M | $1M | $1M | $850.0K | $380.0K | $45.0K | |
| Stock-based Comp | $10M | $3M | $1M | $12M | $19M | $16M | $7M | $2M | $177.0K | |
| Deferred Tax | $19M | $17M | $15M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-16M | $-23M | $-83M | $-4M | $1M | $4M | $-2M | $6M | · | |
| Operating Cash Flow | $-60M | $-59M | $-41M | $-97M | $-98M | $-99M | $-68M | $-38M | $-16M | |
| CapEx | $208.0K | $156.0K | $279.0K | $267.0K | $2M | $1M | $2M | $2M | $383.0K | |
| Investing Cash Flow | $-138.0K | $-156.0K | $-279.0K | $-267.0K | $-2M | $-1M | $-2M | $-2M | $-383.0K | |
| Debt Issued | · | · | · | $0 | $15M | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $15M | · | · | · | · | |
| Stock Issued | · | · | $86.0K | $204.0K | · | · | $129M | $104M | · | |
| Net Stock Activity | · | · | $86.0K | · | · | · | $129M | · | · | |
| Financing Cash Flow | $173M | $172M | $34M | $262.0K | $30M | $173M | $130M | $160M | $17M | |
| Net Change in Cash | $113M | $112M | $-7M | $-97M | $-70M | $73M | $61M | $121M | $606.0K | |
| Taxes Paid | $1M | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-60M | $-59M | $-63M | $-97M | $-100M | $-100M | $-69M | $-39M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -35.8% | -60.3% | 11.9% | -68.8% | -50.1% | -50.7% | -43.7% | -66.0% | · | |
| ROE | -27.7% | -39.8% | 162.5% | -122.1% | -65.6% | -51.8% | -37.1% | -35.8% | · | |
| ROIC | -34.0% | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.6 | 12.6 | 15.8 | 7.6 | 10.3 | 16.1 | 14.0 | 12.3 | · | |
| Quick Ratio | 26.3 | 12.2 | 15.4 | 7.1 | 9.8 | 15.6 | 13.3 | 11.9 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.41 | $9.48 | $2.12 | $1.72 | $4.08 | $6.12 | $5.88 | $5.13 | · | |
| Cash Flow / Share | $-3.28 | $-6.96 | $-1.42 | $-2222.46 | · | · | · | · | · | |
| Cash / Share | $13.54 | $9.51 | $2.20 | $2.11 | $4.56 | $6.25 | $5.91 | $5.31 | · | |
| Dividend / Share | $0.00 | $0.00 | · | · | · | · | · | · | · | |
| EPS (TTM) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-74M | $-58M | $-43M | $-106M | $-119M | $-120M | $-73M | $-46M | · | |
| Market Cap | $391M | $686M | $729M | $374M | $1.92B | $6.95B | $7.64B | $4.76B | · | |
| P/E | -5.2 | -6.8 | -0.5 | -3.5 | -16.6 | · | · | · | · | |
| P/B | 1.6 | 4.9 | 7.7 | 5.0 | 11.3 | 27.3 | 41.1 | 38.9 | · | |
| P / Tangible Book | 1.6 | 4.9 | · | · | 11.3 | 27.3 | · | · | · | |
| P / Cash Flow | -6.5 | -11.6 | -11.5 | -3.8 | -19.6 | -70.4 | -113.0 | -126.3 | · | |
| P / FCF | -6.5 | -11.6 | -11.5 | -3.8 | -19.1 | -69.6 | -110.4 | -120.5 | · | |
| Earnings Yield | -19.4% | -14.8% | -206.9% | -28.4% | -6.0% | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $21M | $16M | $17M | $17M | $13M | $9M | $14M | $7M | $11M | $3M | $8M | $9M | $17M | $18M | $16M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $2M | $-11M | $6M | $5M | $8M | $7M | $7M | |
| Operating Expenses | $24M | $27M | $22M | $22M | $22M | $18M | $14M | $20M | $11M | $13M | $-1M | $10M | $11M | $25M | $25M | $23M | |
| Operating Income | $-24M | $-27M | $-22M | $-22M | $-22M | $-18M | $-14M | $-20M | $-11M | $-13M | $1M | $-10M | $-11M | $-25M | $-25M | $-23M | |
| Interest Income | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $318.0K | $256.0K | $133.0K | $97.0K | $224.0K | · | · | · | |
| Other Non-op | $-5.0K | $-113.0K | $-8.0K | $-31.0K | $-48.0K | $-32.0K | $-96.0K | $-7.0K | $-5.0K | $-403.0K | $390.0K | $-1.0K | $-8.0K | $15.0K | $-321.0K | $-95.0K | |
| Pretax Income | $-22M | · | $-19M | $-19M | $-19M | · | $-12M | $-18M | $-13M | · | · | · | · | · | · | · | |
| Income Tax | $77.0K | · | $254.0K | $0 | $976.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | |
| Net Income | $-22M | $-25M | $-19M | $-19M | $-20M | $-16M | $-12M | $-18M | $-13M | $-15M | $-8M | $-10M | $-10M | $-14M | $-25M | $-23M | |
| EPS (Basic) | $-1.18 | $-1.34 | $-1.03 | $-1.02 | $-1.07 | $-0.93 | $9.68 | $-1.20 | $-4.34 | $-10.97 | $-17.06 | $-7.62 | $-8.51 | $-0.57 | $-0.58 | $-0.52 | |
| EPS (Diluted) | $-1.18 | $-1.34 | $-1.03 | $-1.02 | $-1.07 | $-0.93 | $9.68 | $-1.20 | $-4.34 | $-10.97 | $-17.06 | $-7.62 | $-8.51 | $-0.57 | $-0.58 | $-0.52 | |
| Shares (Basic) | 18,964,008 | 18,769,004 | · | 18,712,767 | 18,680,042 | 17,157,661 | · | 14,729,018 | 2,919,872 | 1,387,303 | · | 1,319,147 | 1,228,778 | 44,037,000 | · | 43,773,000 | |
| Shares (Diluted) | 18,964,008 | 18,769,004 | · | 18,712,767 | 18,680,042 | 17,157,661 | · | 14,729,018 | 2,919,872 | 1,387,303 | · | 1,319,147 | 1,228,778 | 44,037,000 | · | 43,773,000 | |
| EBITDA | $-24M | $-27M | · | $-22M | $-22M | $-18M | · | $-20M | $-11M | $-8M | · | $-23M | $68M | $-25M | · | $-23M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $227M | $237M | $254M | $268M | $287M | $306M | $141M | $159M | $185M | $90M | $29M | $106M | $125M | $72M | $93M | $116M | |
| Prepaid Expense | $4M | $3M | $3M | $4M | $3M | $3M | $6M | $4M | $2M | $1M | $2M | $3M | $4M | $5M | $7M | $10M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $626.0K | · | $805.0K | $792.0K | $845.0K | $1M | $765.0K | |
| Current Assets | $231M | $240M | $257M | $273M | $291M | $310M | $147M | $163M | $187M | $92M | $31M | $109M | $129M | $77M | $100M | $126M | |
| PP&E (Net) | $858.0K | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | · | $3M | $0 | $2M | $3M | $3M | $3M | |
| PP&E (Gross) | · | · | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | · | · | $3M | $3M | $3M | $3M | $3M | $3M | $2M | · | $2M | $4M | $4M | $4M | $4M | $3M | |
| Other Non-current Assets | $626.0K | $663.0K | $640.0K | $597.0K | $287.0K | $138.0K | $156.0K | $190.0K | $13.0K | · | $31.0K | $40.0K | $40.0K | $40.0K | $40.0K | $41.0K | |
| Total Assets | $237M | $247M | $261M | $277M | $295M | $315M | $153M | $169M | $194M | $92M | $39M | $111M | $134M | $83M | $104M | $129M | |
| Accounts Payable | $2M | $3M | $1M | $1M | $3M | $6M | $976.0K | $3M | $4M | $243.0K | $409.0K | $910.0K | $1M | $591.0K | $384.0K | $2M | |
| Accrued Liabilities | $7M | $9M | $7M | $7M | $7M | $5M | $8M | $13M | $20M | $3M | $8M | $5M | $8M | $11M | $12M | $14M | |
| Current Liabilities | $10M | $13M | $10M | $9M | $11M | $14M | $12M | $17M | $26M | $4M | $41M | $8M | $12M | $14M | $13M | $16M | |
| Capital Leases | $3M | $3M | $0 | $0 | $0 | $0 | $132.0K | $523.0K | $905.0K | · | $2M | $105.0K | $134.0K | $352.0K | $188.0K | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Total Liabilities | $13M | $16M | $10M | $9M | $12M | $14M | $12M | $18M | $28M | $4M | $43M | $8M | $12M | $30M | $29M | $31M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $15M | · | $15M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $4.0K | $0 | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $494M | $478M | $474M | $471M | $468M | $466M | $289M | $287M | $285M | · | $6M | · | · | · | · | · | |
| Retained Earnings | $-270M | $-248M | $-223M | $-204M | $-184M | $-164M | $-149M | $-136M | $-118M | $-484M | $-91M | $-468M | $-447M | $-514M | $-489M | $-464M | |
| AOCI | $0 | $0 | $-96.0K | $-75.0K | $-49.0K | $2.0K | $9.0K | $-77.0K | $-61.0K | · | $-11.0K | · | · | · | · | · | |
| Stockholders' Equity | $224M | $230M | $251M | $268M | $284M | $301M | $141M | $150M | $166M | $89M | $-85M | $103M | $122M | $53M | $75M | $98M | |
| Liabilities + Equity | $237M | $247M | $261M | $277M | $295M | $315M | $153M | $169M | $194M | $92M | $39M | $111M | $134M | $83M | $104M | $129M | |
| Shares Outstanding | 19,235,221 | 18,830,436 | 18,738,249 | 18,713,223 | 18,712,138 | 18,671,229 | 14,856,309 | 14,744,477 | 14,734,323 | 44,882,000 | 1,407,753 | 44,558,000 | 44,308,000 | 44,088,000 | 43,916,000 | 43,773,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $285.0K | $304.0K | $333.0K | $342.0K | $340.0K | $360.0K | $508.0K | $424.0K | $713.0K | $377.0K | $373.0K | $488.0K | $289.0K | $328.0K | $351.0K | $336.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $2M | $-154.0K | $321.0K | $294.0K | $-3M | $-2M | $3M | $2M | $3M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Other Non-cash | · | $3M | · | · | · | $360.0K | · | · | · | $-2M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-21M | $-18M | $-14M | $-18M | $-15M | $-13M | $-17M | $-20M | $-15M | $-9M | $-12M | $6M | $-259.0K | $-20M | $-24M | $-16M | |
| CapEx | $79.0K | $19.0K | $0 | $181.0K | $0 | $27.0K | $3.0K | $153.0K | $0 | $4.0K | $50.0K | $221.0K | $214.0K | $8.0K | $0 | $86.0K | |
| Investing Cash Flow | $-59.0K | $-19.0K | $0 | $-166.0K | $55.0K | $-27.0K | $-3.0K | $-153.0K | $0 | $-4.0K | $-50.0K | $-84M | $-214.0K | $-8.0K | $0 | $-86.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $4.0K | · | $73.0K | $0 | $13.0K | $1.0K | $203.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $4.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $12M | $847.0K | $-141.0K | $-457.0K | $-4M | $178M | $-1M | $-6M | $179M | $-668.0K | $34M | $16M | $-324.0K | $55.0K | $59.0K | $60.0K | |
| Net Change in Cash | $-10M | $-17M | $-15M | $-18M | $-19M | $165M | $-18M | $-26M | $164M | $-10M | $22M | $-62M | $-797.0K | $-20M | $-24M | $-16M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-8M | · | · | · | $-20M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.4% | -9.0% | · | -8.5% | -8.2% | -7.8% | · | -12.7% | -7.7% | -7.8% | · | -18.0% | 48.2% | -19.3% | · | -13.3% | |
| ROE | -8.8% | -9.5% | · | -9.1% | -8.9% | -8.2% | · | -14.0% | -8.8% | -9.6% | · | -21.5% | 56.1% | -25.4% | · | -15.8% | |
| ROIC | -10.9% | · | · | -8.2% | -8.3% | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.3 | 18.5 | · | 29.2 | 25.6 | 22.9 | · | 9.4 | 7.2 | 26.2 | · | 14.4 | 11.0 | 5.4 | · | 7.8 | |
| Quick Ratio | 21.9 | 18.3 | · | 28.6 | 25.3 | 22.7 | · | 9.2 | 7.1 | 25.8 | · | 14.0 | 10.7 | 5.1 | · | 7.2 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $11.64 | $12.24 | · | $14.30 | $15.16 | $16.12 | · | $10.20 | $11.29 | $1.98 | · | $2.31 | $2.75 | $1.20 | · | $2.24 | |
| Cash Flow / Share | · | $-0.98 | · | · | · | $-0.76 | · | · | · | $-0.17 | · | · | · | $-460.61 | · | · | |
| Cash / Share | $11.80 | $12.58 | · | $14.34 | $15.36 | $16.40 | · | $10.79 | $12.56 | $2.02 | · | $2.38 | $2.81 | $1.64 | · | $2.65 | |
| Dividend / Share | · | · | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-4.57 | $-4.46 | · | $6.66 | $6.48 | $3.21 | · | $-33.57 | $-39.99 | $-44.16 | · | $-17.28 | $-10.18 | $-2.31 | · | $-2.49 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-86M | $-83M | · | $-67M | $-66M | $-59M | · | $-53M | $-46M | $-44M | · | $-60M | $-73M | $-91M | · | $-109M | |
| Market Cap | $661M | $582M | · | $294M | $372M | $331M | · | $447M | $243M | $689M | · | $823M | $505M | $529M | · | $336M | |
| P/E | -7.5 | -6.9 | · | 2.4 | 3.1 | 5.5 | · | -0.9 | -0.4 | -0.3 | · | -1.1 | -1.1 | -5.2 | · | -3.1 | |
| P/B | 3.0 | 2.5 | · | 1.1 | 1.3 | 1.1 | · | 3.0 | 1.5 | 7.8 | · | 8.0 | 4.1 | 10.0 | · | 3.4 | |
| P / Tangible Book | 3.0 | 2.5 | · | 1.1 | 1.3 | 1.1 | · | 3.0 | 1.5 | 7.8 | · | 8.0 | 4.1 | 10.0 | · | 3.4 | |
| P / Cash Flow | · | -31.6 | · | · | · | -25.3 | · | · | · | -91.1 | · | · | · | -26.1 | · | · | |
| Earnings Yield | -13.3% | -14.4% | · | 42.4% | 32.6% | 18.1% | · | -110.8% | -242.8% | -287.5% | · | -93.5% | -89.3% | -19.2% | · | -32.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-74M | $-58M | $-43M | $-106M | $-119M |
| Seyreltilmiş Hisse Başı Kâr | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 26.6 | 12.6 | 15.8 | 7.6 | 10.3 |
| Cari Oran | 26.3 | 12.2 | 15.4 | 7.1 | 9.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-60M | $-59M | $-63M | $-97M | $-100M |
Kurumsal Sahipler (13F) 132 dosya · $487.9M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
132
Tutulan Değer
$487.9M
Yeni pozisyonlar
26
Çıkan pozisyonlar
10
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 26 (-3 önceki Ç'ye göre) | 10 (-8 önceki Ç'ye göre) | 39 (+3 önceki Ç'ye göre) | 41 (+4 önceki Ç'ye göre) | +85K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FMR LLC | $97.294.233 | 2.830.378 | 19,94% | Hisse senetleri |
| TCG Crossover Management, LLC | $41.418.128 | 1.204.891 | 8,49% | Hisse senetleri |
| Aberdeen Group plc | $39.250.200 | 1.141.824 | 8,04% | Hisse senetleri |
| BlackRock, Inc. | $29.651.600 | 862.592 | 6,08% | Hisse senetleri |
| First Light Asset Management, LLC | $27.524.958 | 800.726 | 5,64% | Hisse senetleri |
| BAKER BROS. ADVISORS LP | $20.892.713 | 607.788 | 4,28% | Hisse senetleri |
| 5AM Venture Management, LLC | $20.853.938 | 606.660 | 4,27% | Hisse senetleri |
| BRAIDWELL LP | $20.518.438 | 596.900 | 4,21% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.802.672 | 488.805 | 3,44% | Hisse senetleri |
| Vestal Point Capital, LP | $14.609.375 | 425.000 | 2,99% | Hisse senetleri |
| VANGUARD GROUP INC | $12.513.872 | 599.898 | 2,56% | Hisse senetleri |
| KENNEDY CAPITAL MANAGEMENT LLC | $9.700.694 | 282.202 | 1,99% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $9.299.108 | 270.461 | 1,91% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $7.789.375 | 226.600 | 1,60% | Hisse senetleri |
| STATE STREET CORP | $7.559.338 | 219.908 | 1,55% | Hisse senetleri |
| Ikarian Capital, LLC | $7.075.647 | 205.837 | 1,45% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $6.412.656 | 186.550 | 1,31% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.054.318 | 176.100 | 1,24% | Alım opsiyonu |
| MARSHALL WACE, LLP | $5.916.833 | 172.101 | 1,21% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $5.689.922 | 165.525 | 1,17% | Hisse senetleri |
| Squarepoint Ops LLC | $4.985.338 | 145.028 | 1,02% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $4.896.673 | 142.448 | 1,00% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $4.036.588 | 117.428 | 0,83% | Hisse senetleri |
| NORTHERN TRUST CORP | $3.915.450 | 113.904 | 0,80% | Hisse senetleri |
| Soleus Capital Management, L.P. | $3.495.388 | 101.684 | 0,72% | Hisse senetleri |
| Woodline Partners LP | $3.437.500 | 100.000 | 0,70% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.245.481 | 94.414 | 0,67% | Hisse senetleri |
| CITADEL ADVISORS LLC | $3.107.260 | 90.393 | 0,64% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $2.541.138 | 73.924 | 0,52% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $2.498.169 | 72.674 | 0,51% | Hisse senetleri |
| SECTORAL ASSET MANAGEMENT INC | $2.440.934 | 71.009 | 0,50% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $2.351.044 | 68.394 | 0,48% | Hisse senetleri |
| JANE STREET GROUP, LLC | $2.262.596 | 65.821 | 0,46% | Hisse senetleri |
| MORGAN STANLEY | $2.247.205 | 65.373 | 0,46% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $2.232.313 | 64.940 | 0,46% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.089.003 | 60.771 | 0,43% | Hisse senetleri |
| JPMORGAN CHASE & CO | $1.831.995 | 55.364 | 0,38% | Hisse senetleri |
| KOTLER KEVIN | $1.668.800 | 80.000 | 0,34% | Hisse senetleri |
| Tetragon Partners GP Ltd | $1.598.988 | 46.516 | 0,33% | Hisse senetleri |
| PFM Health Sciences, LP | $1.568.566 | 45.631 | 0,32% | Hisse senetleri |
| Jump Financial, LLC | $1.491.875 | 43.400 | 0,31% | Hisse senetleri |
| Prosight Management, LP | $1.365.753 | 39.731 | 0,28% | Hisse senetleri |
| Trexquant Investment LP | $1.271.566 | 36.991 | 0,26% | Hisse senetleri |
| Aldebaran Capital, LLC | $1.264.897 | 36.797 | 0,26% | Hisse senetleri |
| ExodusPoint Capital Management, LP | $1.211.341 | 35.239 | 0,25% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $1.080.475 | 31.432 | 0,22% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.046.306 | 30.438 | 0,21% | Hisse senetleri |
| MONIMUS CAPITAL MANAGEMENT, LP | $967.416 | 28.143 | 0,20% | Hisse senetleri |
| Bank of New York Mellon Corp | $867.872 | 25.247 | 0,18% | Hisse senetleri |
| ALPS ADVISORS INC | $658.178 | 19.147 | 0,13% | Hisse senetleri |
Aktivistler ve %5+ sahipler 6 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Timothy A. Springer, TAS Partners LLC, Chafen Lu ×5 başvurular | 07 Nisan 2025 | 31,50% | Değişiklik | · | SEC |
| Terrance McGuire, Polaris Partners IX, L.P., Polaris Partners GP IX, L.L.C., Polaris Founders Capital Fund I, L.P., Polaris Founders Capital Fund Management Co. I, L.L.C., Polaris Founders Capital Fund II, L.P., Polaris Founders Capital Fund Management Co. II, L.L.C., Jonathan Flint ×3 başvurular | 07 Nisan 2025 | 6,30% | Değişiklik | · | SEC |
| Vida Ventures II, LLC, Vida Ventures II-A, LLC, VV Manager II, LLC ×3 başvurular | 07 Nisan 2025 | 0,00% | Değişiklik | · | SEC |
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×2 başvurular | 28 Ekim 2024 | · | İlk başvuru | · | SEC |
| SVLSF VI, LLC, SV Life Sciences Fund VI, L.P., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. ×2 başvurular | 16 Şubat 2021 | · | İlk başvuru | · | SEC |
| Clarus Lifesciences III, L.P., Clarus Ventures III GP, L.P., Blackstone Clarus III L.L.C., Blackstone Holdings II L.P., Blackstone Holdings I/II GP L.L.C., The Blackstone Group Inc., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×4 başvurular | 06 Ağustos 2019 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 33 içeriden öğrenenler · 17 yöneticiler · 15 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Alise Reicin | Chief Executive Officer | 25 Eylül 2026 F | 309.078 | 2 | 0 | $105.500 |
| Erik Ostrowski | Interim CEO, President and CFO | 01 Şubat 2024 M | 29.285 | 0 | 0 | $0 |
| Geoffrey Mackay | President & CEO | 08 Şubat 2023 A | 188.012 | 0 | 0 | $0 |
| Daniel Lochner | Chief Financial Officer | 25 Eylül 2026 F | 58.024 | 1 | 0 | $129.660 |
| Katina Dorton | Chief Financial Officer | 08 Ekim 2018 M | 10.000 | 0 | 0 | $0 |
| Birgitte Volck | President of R&D | 04 Mart 2020 A | · | 0 | 0 | $0 |
| Christian Cortis | Chief Operating Officer | 20 Haziran 2024 A | 126.368 | 0 | 0 | $0 |
| Peter Mcnamara | Chief Scientific Officer | 30 Eylül 2026 S | 54.305 | 0 | 8 | $-288.006 |
| Marcella K. Ruddy | Chief Medical Officer | 25 Eylül 2026 F | 67.157 | 0 | 3 | $-363.000 |
| Marc Schwabish | Chief Business Officer | 25 Eylül 2026 F | 44.903 | 0 | 0 | $0 |
| Azadeh Golipour | Chief Technology Officer | 01 Şubat 2024 M | 55.872 | 0 | 0 | $0 |
| Essra Ridha | Chief Medical Officer | 01 Şubat 2024 M | 15.881 | 0 | 0 | $0 |
| Steven Avruch | Chief Legal Officer | 01 Şubat 2024 M | 22.022 | 0 | 0 | $0 |
| Deanna M Petersen | Chief Business Officer | 08 Şubat 2023 A | · | 0 | 0 | $0 |
| Christopher Mason | Chief Scientific Officer | 10 Haziran 2021 A | · | 0 | 0 | $0 |
| Diana Escolar | Chief Medical Officer | 10 Haziran 2021 A | · | 0 | 0 | $0 |
| Nerissa Kreher | Chief Medical Officer | 08 Ekim 2018 M | 2.942 | 0 | 0 | $0 |
| Stefan Vitorovic | Yönetim kurulu üyesi | 09 Haziran 2026 A | 27.774 | 0 | 0 | $0 |
| Praveen P. Tipirneni | Yönetim kurulu üyesi | 09 Haziran 2026 A | 3.037 | 0 | 0 | $0 |
| Phillip B. Donenberg | Yönetim kurulu üyesi | 09 Haziran 2026 A | 2.000 | 0 | 0 | $0 |
| Timothy A. Springer | Yönetim kurulu üyesi | 09 Haziran 2026 A | 1.503.358 | 0 | 0 | $0 |
| Jessica Caroline Chutter | Yönetim kurulu üyesi | 08 Haziran 2026 A | · | 0 | 0 | $0 |
| Terrance McGuire | Yönetim kurulu üyesi | 09 Haziran 2025 A | 573.062 | 0 | 0 | $0 |
| Christopher Paige | Yönetim kurulu üyesi | 06 Haziran 2023 A | 252.512 | 0 | 0 | $0 |
| Annalisa Jenkins | Yönetim kurulu üyesi | 06 Haziran 2023 A | · | 0 | 0 | $0 |
| Philip J. Vickers | Yönetim kurulu üyesi | 06 Haziran 2023 A | 4.800 | 0 | 0 | $0 |
| Gail M Farfel | Yönetim kurulu üyesi | 06 Haziran 2023 A | · | 0 | 0 | $0 |
| Bruce Booth | Yönetim kurulu üyesi | 06 Haziran 2023 A | 5.567.289 | 0 | 0 | $0 |
| Ian T Clark | Yönetim kurulu üyesi | 06 Haziran 2023 A | · | 0 | 0 | $0 |
| Scott Requadt | Yönetim kurulu üyesi | 25 Haziran 2018 C | 2.962.325 | 0 | 0 | $0 |
| ATLAS VENTURE ASSOCIATES X, L.P. | 10% sahip | 13 Şubat 2020 J | 3.710.052 | 0 | 0 | $0 |
| Francois Nader | · | 01 Nisan 2026 A | · | 0 | 0 | $0 |
| Leonard Braden Michael | · | 20 Haziran 2024 J | 33.333 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 20 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,62% | 10.265 NS | 31 Temmuz 2026 | N-PORT |
| IWC · iShares Trust | 0,07% | 34.693 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 1.339 SH | 02 Ekim 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 7.356 SH | 19 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,02% | 70.963 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 58.897 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,01% | 264.002 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 4.882 NS | 31 Temmuz 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 19.539 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,00% | 371 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 7.996 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 5.450 SH | 03 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 975 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1.127 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 111.919 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 364.413 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.713 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.002 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,00% | 25.446 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 77.593 SH | 11 Eylül 2026 | Günlük |
TECX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 16 analist
AL
Medyan hedef
$78.00
+246,1%
6 37,5%
Güçlü Al
9 56,2%
Al
1 6,2%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
8 analist · 2026-10-03Ortalama hedef $76.62 +240,0%
← Tüm hedeflerin altında
Mevcut fiyat $22.54
Düşük$60.00
Ortalama$76.62
Yüksek$93.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| DMAC | $428M | · | · | · | -78.7% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | · |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | · |
| EIKN | · | · | · | · | · | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026